A New Option for Heart Failure Care
For people living with Chronic Heart Failure (CHF), stability can feel uncertain. LuciVeric (Vericiguat 10 mg) offers a targeted approach to support heart function and reduce hospital visits.
How LuciVeric Works
LuciVeric acts on the nitric oxide–sGC–cGMP pathway, which is often weakened in heart failure.
What this means in simple terms:
- Helps blood vessels relax
- Improves blood flow
- Reduces strain on the heart
This allows the heart to pump more efficiently and with less effort.
Key Benefits
1. Reduces Heart Strain
The heart works less hard, making daily activities easier.
2. Improves Blood Circulation
Better oxygen and nutrient delivery throughout the body.
3. Lowers Risk of Hospitalization
Helps reduce the chance of sudden worsening of symptoms and need for hospitalization.
4. Works with Other Treatments
Used alongside standard heart failure medications as part of a combined treatment plan.
5. Enhances Quality of Life
Patients may feel more stable, energetic, and confident in daily life.
Clinical Evidence
In the VICTORIA clinical trial:
- Over 2,500 patients participated
- Treatment lasted up to 2.6 years
- Results showed reduced cardiovascular risk and fewer hospitalizations in appropriate patients
Side effects were generally manageable under medical supervision.
Not a Cure, But Strong Support
LuciVeric does not cure heart failure, but it helps stabilize the condition, reduce worsening episodes, and improve daily functioning when used as prescribed.
Conclusion
LuciVeric represents an important step forward in heart failure care, offering patients a more stable and manageable path forward when combined with comprehensive medical treatment.
